fbpx Insight on Securing SBIR Funding - Videos | JLABS

Insight on Securing SBIR Funding

Insight on Securing SBIR Funding

Insight on Securing SBIR Funding

The Small Business Innovation Research (SBIR) is one of the largest sources of early-stage capital for technology commercialization in the United States. NIH’s SBIR program invests over 1 billion dollars into health and life science companies that are creating innovative technologies that align with NIH’s mission to improve health and save live, and also allows US-owned and operated small businesses to engage in federal research and development that has strong potential for commercialization.

Join our webinar with SBIR experts to learn more about SBIR funding, including eligibility, how to apply, the application road map and more. Our panel experts will share what the different NIH groups are looking for in an application, what their group offers to companies, application do’s and don’ts, and will also be answering your key questions. You don’t want to miss this! 

Check out more On-Demand Webinars

The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only.  This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates.  The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.

Related content